2049P Osimertinib-related muscle cramps as a common adverse event: A real-world data analysis in the post-approval setting

Autor: Moreira, G.F., Borchardt, I., Dias, F.C., Taveira, F.T., Pina, L.D.O., Rocha, W.M., Montella, T.C., de Melo, A.C., Ferreira, C.G.M.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S1084-S1085
Databáze: ScienceDirect